MapLight Therapeutics

MapLight Therapeutics

United States; Massachusetts United States; Americas; North America
Is it you?
Investor info
Type
Fund of Funds
Stage focus
  • Early stage VC
Industry focus
Description
MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing targeted therapies for central nervous system and neuropsychiatric disorders by leveraging its proprietary platform to map neural circuits and identify new drug targets.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
Medical Devices
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.